Kovitz Investment Group Partners LLC Purchases New Position in Tempus AI, Inc. (NASDAQ:TEM)

Kovitz Investment Group Partners LLC acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 24,186 shares of the company’s stock, valued at approximately $1,367,000.

A number of other hedge funds have also recently added to or reduced their stakes in TEM. NEA Management Company LLC bought a new stake in shares of Tempus AI during the second quarter worth about $160,048,000. Novo Holdings A S acquired a new position in Tempus AI in the 2nd quarter valued at approximately $142,605,000. Revolution Growth Management Company Inc. bought a new position in shares of Tempus AI during the second quarter valued at $128,133,000. ARK Investment Management LLC lifted its holdings in shares of Tempus AI by 355.0% during the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after purchasing an additional 1,855,459 shares during the period. Finally, Alphabet Inc. bought a new stake in shares of Tempus AI in the second quarter worth $54,289,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Trading Down 3.2 %

Shares of NASDAQ:TEM opened at $45.00 on Wednesday. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $79.49. The business has a 50 day moving average price of $53.18. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Guggenheim assumed coverage on Tempus AI in a research report on Monday. They set a “buy” rating and a $74.00 target price for the company. Piper Sandler reissued a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and upped their price target for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Loop Capital lifted their price objective on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Finally, Bank of America lowered Tempus AI from a “buy” rating to a “neutral” rating and upped their target price for the company from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $56.20.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.